Reata Pharmaceuticals
Utility Patents

Last updated:

List of all Reata Pharmaceuticals patents 12 in total

Status Patent
Grant
Utility: Co-crystal forms of a novobiocin analog and proline External link
Filling date: 8 Sep 2025 Issue date: 2 Aug 2022
Grant
Utility: Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses External link
Filling date: 8 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators External link
Filling date: 8 Sep 2025 Issue date: 7 Dec 2021
Grant
Utility: Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 External link
Filling date: 8 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 3 Aug 2021
Grant
Utility: Imidazolyl tricyclic enones as antioxidant inflammation modulators External link
Filling date: 8 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof External link
Filling date: 8 Sep 2025 Issue date: 23 Mar 2021
Grant
Utility: C17-heteroaryl derivatives of oleanolic acid and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 26 Jan 2021
Grant
Utility: Co-crystal forms of a novobiocin analog and proline External link
Filling date: 8 Sep 2025 Issue date: 21 Jul 2020
Grant
Utility: Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 External link
Filling date: 8 Sep 2025 Issue date: 11 Feb 2020
Grant
Utility: C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 10 Dec 2019
Grant
Utility: C17-heteroaryl derivatives of oleanolic acid and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 3 Sep 2019

Showing 1 to 12 of 12 patents.